Pages that link to "Q48473494"
Jump to navigation
Jump to search
The following pages link to Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. (Q48473494):
Displaying 50 items.
- SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy (Q21560963) (← links)
- SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy (Q21562176) (← links)
- Glutamate and neurotrophic factors in neuronal plasticity and disease (Q24653626) (← links)
- Therapeutic neuroprotective agents for amyotrophic lateral sclerosis (Q27015029) (← links)
- Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition (Q28468536) (← links)
- Phase II open label study of valproic acid in spinal muscular atrophy (Q28475498) (← links)
- Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening (Q28547585) (← links)
- Synuclein alpha (Q28560432) (← links)
- The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms (Q28568768) (← links)
- FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers (Q28570740) (← links)
- Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons (Q28571794) (← links)
- Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation (Q28572236) (← links)
- α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity (Q28572683) (← links)
- Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease (Q28576367) (← links)
- Aberrant histone acetylation promotes mitochondrial respiratory suppression in the brain of alcoholic rats (Q30392399) (← links)
- Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons (Q33565820) (← links)
- Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models (Q33566724) (← links)
- Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology (Q33603777) (← links)
- The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy (Q33830937) (← links)
- Nanomolar concentration of alpha-synuclein enhances dopaminergic neuronal survival via Akt pathway (Q34094699) (← links)
- Potential molecular and cellular mechanism of psychotropic drugs (Q34129880) (← links)
- Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions (Q34144718) (← links)
- Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening (Q34356116) (← links)
- Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism (Q34839640) (← links)
- Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression (Q34991077) (← links)
- Potent neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction. (Q35051680) (← links)
- Aged monkey brains reveal the role of ubiquitin-conjugating enzyme UBE2N in the synaptosomal accumulation of mutant huntingtin (Q35063149) (← links)
- Aspects of innate immunity and Parkinson's disease (Q35813131) (← links)
- The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein (Q35969703) (← links)
- A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway (Q35997723) (← links)
- GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder (Q36062876) (← links)
- Transcriptional Regulation of the Astrocytic Excitatory Amino Acid Transporter 1 (EAAT1) via NF-κB and Yin Yang 1 (YY1). (Q36093103) (← links)
- Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia (Q36185344) (← links)
- Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells (Q36544286) (← links)
- Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy (Q36577891) (← links)
- Epigenetics-Based Therapeutics for Neurodegenerative Disorders (Q36697733) (← links)
- Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions (Q36881831) (← links)
- Current Therapy of Drugs in Amyotrophic Lateral Sclerosis (Q36925891) (← links)
- Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons (Q36965800) (← links)
- A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease. (Q37120413) (← links)
- Epigenetic mechanisms in cerebral ischemia. (Q37150340) (← links)
- Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3 (Q37220495) (← links)
- Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease (Q37257402) (← links)
- α-Synuclein overexpression represses 14-3-3θ transcription (Q37259132) (← links)
- Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity (Q37341162) (← links)
- Multiple roles of HDAC inhibition in neurodegenerative conditions. (Q37407855) (← links)
- SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy (Q37466393) (← links)
- Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation (Q37631143) (← links)
- Valproic Acid Protects Primary Dopamine Neurons from MPP+-Induced Neurotoxicity: Involvement of GSK3β Phosphorylation by Akt and ERK through the Mitochondrial Intrinsic Apoptotic Pathway (Q37737705) (← links)
- Epigenetic regulation of gene expression in physiological and pathological brain processes (Q37870034) (← links)